Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Moss Genomics, Inc. ( (TSE:MOSS) ) is now available.
Moss Genomics Inc. has completed a non-brokered private placement, issuing 555,555 common shares at $0.18 per share, raising $100,000 for general working capital. Additionally, the company issued over 5 million shares as part of asset purchase agreements to acquire Ethereum, marking the completion of transactions first announced in February 2025. This move increases Moss’s total outstanding shares to over 63 million and underscores its commitment to leveraging blockchain technology for its operations. The company will hold its Annual and Special General Meeting virtually on November 13, 2025.
More about Moss Genomics, Inc.
Moss Genomics is a company focused on developing a secure and user-controlled platform for genomic data. Their platform allows individuals to vault their DNA, manage access permissions, and engage in research monetization opportunities. The company leverages Ethereum-based infrastructure to support its development, DNA sequencing services, and future platform operations, aiming to advance decentralized and privacy-preserving genomics in health, identity, and research.
Average Trading Volume: 15,683
Technical Sentiment Signal: Sell
Current Market Cap: C$5.14M
Learn more about MOSS stock on TipRanks’ Stock Analysis page.